Background: Skin wounds can occur for many reasons, including UV radiation, mechanical burns, trauma, and chronic inflammation caused by metabolic factors. In Mongolia, as of 2022, household burns were the top 5 causes of injuries, the leading cause of injuries in children aged 0-5, and accounted for 18.4% of all illnesses in children aged 0-5. Skin burns and wounds take a long time to heal, which causes emotional, aesthetic, and economic stress for doctors. Developing in novative, effective, and low-side effects therapeutic products to improve wound healing is of great clinical and economic importance. The lack of research on the effects of bacterial metabolites and aloe vera (Aloe barbadensis Miller) on burn wounds was the basis for our research. Aim: To determine the effects of a mixture of bacterial metabolites and aloe vera on burn wounds in experimental animals. Materials and Methods: Eight-week-old BALB/c mice were divided into three groups: control group, bacterial metabo lite group, and aloe vera group. The mice were anesthetized, and the dorsal hair was shaved over a 2×2 cm area using an electric clipper. A second-degree burn wound model was created by exposing the shaved dorsal skin to hot air at 200°C for 10 seconds. A total of 100 μL of a bacterial metabolite suspension mixed with aloe vera at a 1:1 ratio was applied evenly to the center of the wound. Wound images were captured daily, and wound areas were measured using ImageJ software. Healing was evaluated on days 7, 14, and 21 of treatment and compared with the control group. The initial wound size was defined as 100%, and wound closure percentages were calculated accordingly. Burn skin tissues from both experimen tal and control groups were subjected to immunofluorescence staining for the vascular marker α-SMA (Thermo Fisher Scientific). Statistical analysis: The differences between the control and experimental groups were analyzed using an independent t-test using GraphPad Prism 10 software, and the mean, standard deviation, and statistical correlation were calculated. Results: The effect of the mixture of bacterial metabolites and aloe vera (Aloe barbadensis Miller) on the healing of burn wounds in experimental mice was compared with the control group. The wound size at 7 days was 82.1% in the control group and 83.7% in the experimental group (p<0.197), at 14 days was 62.6% in the control group and 58.1% in the exper imental group (p<0.0001), at 21 days was 50.7% in the control group and 32.7% in the experimental group (p<0.0001). No statistically significant difference in wound healing was observed between the groups at day 7; however, significant differences were observed at days 14 and 21. Immunofluorescence analysis revealed uniform expression of α-SMA-pos itive cells in the experimental group at 7, 14, and 21 days of treatment, whereas α-SMA expression was not detected in the control group. Conclusion The combination of bacterial metabolites and aloe vera promotes wound healing in experimental mouse burn wounds.

Background: Plants rich in essential oils belong to more than 50 families, including Asteraceae, Rutaceae, and Lamiaceae. These plants are widely used in food, traditional and modern medicine, perfumery, cosmetics, and pharmaceutical industries. Approximately 3,000 types of essential oils have been identified, of which more than 300 are utilized for industrial and commercial purposes. Essential oils exhibit antimicrobial, anti-inflammatory, anticancer, cytotoxic, and antioxidant activities and are therefore widely applied in medical research. In Mongolia, the extreme climate, distinct ecological regions, and the prevalence of pastoral livestock husbandry provide a scientific basis for investigating essential oil–containing plants, their chemical composition, and biological activities. Among them, Juniperus Sabina L. is of particular theoretical and practical interest. Aim: To determine the non-toxic dose of essential oil extracted from Juniper Sabina L. on neural cells. Materials and Methods: This study was conducted at the Institute of Bio-Medicine, MNUMS. Ethical approval was obtained from the Research Ethics Committee of MNUMS (Meeting date: November 21, 2025; Protocol No. 2025-26/0301). BV2 microglial and N2a neuronal cell lines were cultured under standard conditions at 37°C in a 5% CO₂ incubator. Cells were maintained in appropriate culture media, and their growth and morphology were monitored microscopically before experimentation. Cell viability was assessed using the MTT assay. BV2 microglial cells were seeded into 96-well plates at a density of 2×10⁴ cells/well and incubated for 24 hours. Essential oil was added at concentrations ranging from 50–500 µg/mL and incubated for an additional 24 hours. After treatment, MTT reagent was added and incubated for 3 hours. The resulting formazan crystals were dissolved in dimethyl sulfoxide (DMSO), and absorbance was measured at 630 nm. Cell viability was calculated based on absorbance values to determine the non-toxic concentration of the essential oil. Result: The cytotoxic effects of the essential oil were evaluated in BV2 microglial and N2a neuronal cells using the MTT assay. In N2a neuronal cells, concentrations of 50, 100, 200, and 300 µg/mL did not significantly affect cell viability, whereas 400 and 500 µg/mL reduced cell viability, indicating cytotoxic effects. Conclusion According to MTT assay results, the essential oil of Juniperus sabina showed no cytotoxic effect on N2a neuronal cells at concentrations of 50, 100, 200, and 300 µg/mL, while cytotoxic effects were observed at 400 and 500 µg/mL. In BV2 microglial cells, concentrations of 50, 100, and 200 µg/mL were non-toxic, whereas concentrations above 300 µg/mL exhibited cytotoxic effects.

Background: Hemophilia A (HA) and hemophilia B (HB) are monogenic bleeding disorders caused by pathogenic variants in the F8 and F9 genes, respectively, which are located on the X chromosome and result in deficiencies of coagulation factor VIII (FVIII) and factor IX (FIX). The diseases predominantly affect males, while females are usually asymptomatic heterozygous carriers. Identification of female carriers among relatives of affected males is important for preventing bleeding complications associated with surgery and childbirth. Aim: The main aim of this study was to detect carrier and non-carrier women and compare some phenotypes. Materials and Methods: The study included 50 female relatives of 32 male patients diagnosed with hemophilia A and 13 female relatives of 8 male patients diagnosed with hemophilia B, giving a total of 63 female relatives. Molecular genetic testing was performed to identify the pathogenic variants previously detected in the probands and to determine the carrier status of female relatives. Among them, 33 confirmed carriers and 18 non-carriers completed a 28-item questionnaire comprising three sections to assess bleeding-related symptoms. The questionnaire evaluated easy bruising, duration of menstruation, postpartum bleeding, and bleeding following injuries, surgical procedures, and dental procedures. Questionnaire findings were compared between molecularly confirmed carriers and non-carriers. Continuous variables were compared using the Mann–Whitney U test, while categorical variables were analyzed using Fisher’s exact test in R software. In female relatives of patients with hemophilia A, plasma FVIII activity was also measured. Result: Molecular genetic testing was performed in 52 female relatives. Eleven women were excluded from carrier-status analysis because no pathogenic variant was identified in the F8 or F9 gene of their respective probands. Among 43 female relatives of patients with hemophilia A who underwent carrier testing, 26 (60.4%) were identified as carriers and 17 (39.5%) as non-carriers. Among eight male patients with hemophilia B, pathogenic F9 variants were identified in six; among their seven female relatives, six were confirmed carriers and one was a non-carrier. The mean FVIII activity among heterozygous HA carriers was 58.5±20.6 IU/dL (n=17), which was significantly lower than that of non-carriers (101±28.8 IU/dL; p<0.001). Of the nine bleeding-related symptoms assessed, only easy bruising of the skin was significantly more common among carriers (OR=6.8; p=0.0069). Although prolonged menstrual bleeding and bleeding after childbirth, surgery, or dental procedures were reported among some carriers, no statistically significant differences were observed between carriers and non-carriers. Conclusion Among female relatives of males diagnosed with Hemophilia A or B in Mongolia, 32 (64%) of 50 women were identified as carriers and 18 (36%) as non-carriers. Plasma FVIII activity was significantly lower in HA carriers than in non-carriers (58.5±20.6 IU/dL vs. 101±28.8 IU/dL; p<0.001). Easy bruising was significantly more frequent among carriers (OR=6.8; p=0.0069). These findings support the importance of molecular genetic testing for identifying female carriers and recognizing women who may be at increased risk of bleeding, particularly in the context of surgery and childbirth.

Background: Maintaining the concentration of a drug in the blood at a therapeutic level is crucial for enhancing treatment efficacy and reducing adverse effects. Conventional dosage forms are rapidly absorbed, causing a quick rise in the drug concentration in the blood, but it soon declines. As a result, frequent dosing is required in chronic or acute conditions. This can lead to drug concentrations exceeding therapeutic levels, increasing toxicity, or failing to reach the required level. To address these limitations, drug delivery systems (DDS) have been intensively developed over the past few decades. Among these systems, microencapsulation technology enables targeted delivery of the drug within the body, maintains stability, controls release, improves bioavailability, reduces side effects, and protects the active pharmaceutical ingredient from degradation or elimination, delivering it specifically to the necessary tissues. These characteristics provided the rationale for conducting this study. Aim: Select a suitable polymer for microcapsule formation, develop a production technology using the emulsion solvent evaporation method, and evaluate certain morphological characteristics of the resulting microcapsules. Materials and Methods: The microcapsules were prepared using an O/W emulsion solvent evaporation method. Dichloromethane (DCM) was used as the solvent, and the wall materials were solutions of chitosan (2% w/v) and gelatin (5% w/v), which are polymers combining biodegradability and biocompatibility. These solutions were mixed in a total of eight different ratios and emulsified into an aqueous phase containing polyvinyl alcohol (PVA, 1% w/v) using a high-speed homogenizer at 8000–10000 rpm to form the emulsion, followed by solvent evaporation. The resulting microcapsules were freeze-dried to obtain dry microcapsule forms. The morphology and surface structure of the microcapsules were characterized using light microscopy and scanning electron microscopy (SEM), while their size and distribution were analyzed using the ImageJ software. Result: To determine the optimal wall material for the microcapsules, a total of eight formulation ratios were prepared, and the emulsion stability and viscosity were evaluated. Chitosan-dominant formulations (F1, F7, F8) exhibited excessively high viscosity and a tendency for the system to thicken, which reduced the uniformity and stability of the emulsion. In contrast, formulations with low or imbalanced gelatin content (F2, F3) failed to achieve complete emulsion stabilization and showed significant phase separation. The F5 formulation demonstrated the best stability, minimal phase separation, and appropriate viscosity, making it the optimal choice for microcapsule wall preparation. The chitosan-to-gelatin ratio of 1:2 (F5 formulation) was found to be the most suitable in terms of complete microcapsule formation, spherical shape, uniform surface, and proper viscosity. Microcapsules of the F5 formulation had an average diameter of 290±30 µm, were spherical, and maintained shape stability even after freeze-drying. A microcapsule preparation technology based on the emulsion method was developed experimentally, and the most suitable conditions were established. Conclusion 1. The results of the study indicated that a chitosan-to-gelatin ratio of 1:2 was the most suitable formulation for microcapsules in terms of complete formation, spherical shape, and uniform surface characteristics. 2. When the gelatin content increased, microcapsule morphology deteriorated and aggregation tendencies were observed, whereas higher chitosan content increased the viscosity of the solution, which affected the stability of the emulsion and resulted in non-uniform microcapsule sizes. 3. The 1:2 chitosan-gelatin ratio is therefore crucial for microcapsule preparation, and this wall composition can be applied in further studies involving drug-loaded microcapsules.

Background: Honey is a natural biologically active substance with antibacterial, antioxidant, anti-inflammatory, and tissue regeneration–promoting properties, and it has traditionally been used in wound treatment for centuries. Numerous studies have confirmed that the phenolic compounds, enzymes, hydrogen peroxide, and amino acids contained in honey inhibit bacterial growth and accelerate wound healing. Wound infections are commonly caused by pathogenic bacteria such as Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli which are major factors that delay wound healing and lead to complications. However, the direct application of honey to wounds presents challenges such as adhesiveness, absorption, dose stability, and sterility. Therefore, it is necessary to formulate honey into a suitable pharmaceutical dosage form to facilitate its use and introduce natural raw materials into therapeutic practice. Thus, incorporating honey as the main active ingredient into a hydrogel dressing could enable the development of a novel therapeutic wound dressing that is physically and chemically stable and capable of maintaining an optimal moist wound environment, which is essential for wound healing. Honey-containing hydrogel dressings differ from other dressings in their ability to balance the wound environment, absorb and retain moisture, provide antibacterial and anti-inflammatory effects, and support tissue regeneration. The significance of this study lies not only in investigating the antibacterial activity of honey but also in determining the bacterial killing time, thereby providing useful data for future studies. Aim: To investigate the antibacterial activity of honey and determine its bacterial killing time. Materials and Methods: Domestic honey samples were compared with imported honey samples in terms of antibacterial activity and bacterial killing time. Domestic honey samples were coded as D1, D2, D3, C1, and C2, while the imported honey sample was coded as M. A total of six honey samples were evaluated. Using the broth microdilution method, the antibacterial activity against four bacterial strains commonly associated with burn wound infections Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 28583, Klebsiella pneumoniae ATCC 1706, and Escherichia coli ATCC 25218 was determined and compared. Subsequently, bacterial killing time was evaluated using the broth dilution method with honey concentrations prepared at ratios of 7:3 (70%), 5:5 (50%), and 4:6 (40%). Results: The antibacterial activities of D1, D2, D3, C1, C2, and M honey samples against S. aureus, P. aeruginosa, K. pneumoniae, and E. coli were determined. Among them, D3, C2, and M honey samples showed stronger antibacterial activity. Therefore, these three honey samples were further investigated by determining bacterial killing time over an 18-hour period. For D3 honey diluted at a 7:3 ratio, the killing time was 15 hours for S. aureus and 7 hours for P. aeruginosa, while the killing times for K. pneumoniae and E. coli exceeded 18 hours. D3 honey diluted at a 5:5 ratio showed bacterial killing times exceeding 18 hours for all tested bacteria. For C2 honey diluted at a 7:3 ratio, the killing times were 16 hours for S. aureus, 12 hours for P. aeruginosa, 16 hours for K. pneumoniae, and 17 hours for E. coli. C2 honey diluted at a 5:5 ratio killed E. coli in 18 hours, whereas the killing times for S. aureus, P. aeruginosa, and K. pneumoniae exceeded 18 hours. For M honey diluted at a 7:3 ratio, the killing times were 8 hours for S. aureus, 7 hours for P. aeruginosa, 9 hours for K. pneumoniae, and 8 hours for E. coli. M honey diluted at a 5:5 ratio killed S. aureus in 9 hours, P. aeruginosa in 10 hours, K. pneumoniae in 10 hours, and E. coli in 9 hours. Conclusions 1. The antibacterial activity of honey against Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli varied depending on honey concentration, with honey concentrations of 40–45% demonstrating the highest antibacterial activity. Furthermore, M honey exhibited the strongest antibacterial activity compared to the other honey samples. 2. In determining bacterial killing time, the domestic honey samples killed bacteria within 9 hours, whereas the imported honey sample killed bacteria within 7 hours.

Background: Of the 7,678 plant species growing in Mongolia, more than 1,230 are considered medicinal plants; however, around 900 of these remain unstudied, and only about 200 species are currently used in medical practice. In recent years, the use of natural products in therapy has increased, and research in this field has been rapidly developing. Schizonepeta multifida (L.) Briq., a plant belonging to the Lamiaceae family, is widely distributed in Mongolia, Siberia, and East Asia, and is traditionally used to treat colds, fever, and inflammatory diseases. Phytochemical studies have shown that its essential oil contains terpenoid compounds such as pulegone and limonene, as well as flavonoids. These compounds are known to exhibit antioxidant, anti-inflammatory, and neuroprotective effects; however, comprehensive studies on these activities of Schizonepeta multifida growing in Mongolia are limited. Aim: To determine the antioxidant activity, cytotoxicity, and anti-inflammatory effects of Schizonepeta multifita Briq. essential oil and to evaluate its anti-stress effects in an experimental chronic stress animal model. Materials and Methods: The study was conducted at the Institute of Bio-Medicine, Mongolian National University of Medical Sciences. The aerial parts of Schizonepeta multifida were subjected to hydrodistillation using a Clevenger apparatus to obtain essential oil, and the yield was calculated. Antioxidant activity was measured at 517 nm using a spectrophotometer (Agilent BioTek Epoch 2). Cytotoxicity was assessed in BV2 and N2a cell lines using the MTT assay, after which inflammatory markers (IL-6 and TNF-α) were determined in cell cultures using ELISA. For the induction of chronic stress, C57/BL6 mice were divided into healthy control, negative control, and experimental groups. A total of 10 different chronic stress models were randomly applied twice daily for 28 days. Anti-stress effects were evaluated using the forced swim test. Data analysis was performed using Prism 10 software. Results: The yield of essential oil from Schizonepeta multifida was 0.3±0.03%. The antioxidant activity, assessed by the DPPH radical scavenging method, showed an IC₅₀ value of 262.7±2.95 µg/mL, indicating antioxidant potential. Cytotoxicity assays in BV2 and N2a cell lines showed toxic effects starting from a concentration of 200 µg/mL. The essential oil significantly reduced inflammatory markers IL-6 and TNF-α at concentrations of 50, 100, and 200 µg/mL (p<0.05). In the forced swim test, there was a statistically significant difference (p<0.05) between the disease control group and the experimental group. Conclusion The essential oil of Schizonepeta multifida exhibits antioxidant, anti-inflammatory, and anti-chronic stress effects.

Background: Currently, colorectal cancer (CRC) ranks as the third most common cancer and the second leading cause of cancer-related mortality worldwide. CRC frequently metastasizes to the liver (50%), lungs (10–15%), peritoneum (4%), bones (10.7%–23.7%), brain (0.3%–6%), and spinal cord. Approximately 35% of CRC cases are diagnosed before distant metastasis, 36% upon lymph node involvement, and 23% after distant organ metastasis. Although several studies have established primary tumor models in mice in our country, there are limited studies on experimental lung metastasis models, prompting the need for this research. Aim: To establish and evaluate a lung metastasis model of colorectal cancer in C57BL/6J mice using the MC38 cell line. Materials and Methods: This study was conducted at the Institute of Biomedical Sciences, Mongolian National University of Medical Sciences. Approval was obtained from the Ethics Review Board of the Mongolian National University of Medical Sciences (2023/3-09) and all laboratory safety regulations and protocols were strictly followed. Male C57BL/6J mice bred at the Experimental Animal Center of Mongolian National University of Medical Sciences were used. MC38 murine colorectal carcinoma cells were cultured and injected intravenously (via the tail vein) at a concentration of 0.25×10⁶ cells per mouse (n=12) to induce lung metastasis. Histological analysis was subsequently performed. Results: Histological examination revealed significant alterations in lung tissue architecture, characterized by areas of dense infiltration by pleomorphic, hyperchromatic cells, disrupting the normal alveolar structure. No histological abnormalities were observed in other organs. Conclusion Intravenous injection of MC38 colorectal adenocarcinoma cells into the tail vein of C57BL/6J mice successfully induced lung metastases, characterized by hyperchromatic, pleomorphic cell infiltrates forming glandular structures within the lung parenchyma.

Outcomes of the retinopathy of prematurity screening and treatment in Mongolia Background: Retinopathy of prematurity (ROP) is a disease characterized by abnormal retinal vasculature that can have devastating visual consequences. Despite evidence that early detection and treatment can prevent blindness, ROP remains a leading cause of pediatric blindness worldwide. We aimed at investigating the outcomes of ROP screening, intravitreal anti–vascular endothelial growth factor (VEGF) and laser surgery in the treatment ROP and describe an evidence-based and specific process for identifying birth weight and gestational age screening guidelines in Mongolia utilizing telemedicine. Materials and methods: This was a retrospective of prematurity infants screened ROP from 2012 September to July 2020 and prospective cohort study of premature infants with treatment-requiring ROP who received intravitreal injections, laser surgery and combined therapy from 2015 December 01 to January 31, 2017. Demographic factors, diagnosis and clinical course were recorded in a de-identified manner using REDCap, a secure, web-based platform to collect image and demographic data. The IRB approved the study protocol not requiring parental consent due to the de-identified nature of the data which was used for program monitoring purposes. Indirect ophthalmoscopy and Retinal imaging was performed using RetCam (Natus Medical, Pleasanton, CA) and images were uploaded to the web-based platform which could be accessed by the Mongolian ophthalmologist for reference. Each eye was evaluated by the local Mongolian ophthalmologist for the presence or absence of ROP, zone of vascularization, stage, plus disease, and aggressive posterior ROP (AP-ROP). The diagnosis and classification of ROP for this current study were determined by examination using indirect ophthalmoscopy, and treatment plans were determined according to the International Classification for ROP and the Early Treatment for ROP Study (ET-ROP).2,13 Regression analysis to determine association between BW and GA and the development of ROP. Results: A total of 9126 premature infants with BW ≤ 2500 g and/or GA ≤ 36 weeks were screened for ROP during the study period. 327 (3.5%) of the 9126 infants screened required treatment. The193 infants who received ROP screening had a mean GA of 30.09 ± 1.7 weeks, and mean BW of 1500.3 ± 125.42g. The BW of infants in this study ranged from 750g to 2000g, and the GA at birth ranged from 25 to 35 weeks. The BW of infants in this study ranged from 750g to 2000g, and the GA at birth ranged from 25 to 35 weeks. There were 96 boys (49.7%) and 97 girls (50.3%). Among infants receiving treatment, the highest BW was 2000g (born at 31 weeks GA), and the oldest was 34 weeks (with a BW of 1300g). The distribution of birth weight and gestational age in Mongolia was similar to other low-middle income countries, with higher birth weight and older gestational age. As birth weight and gestational age decreased, relative risk of developing ROP increased. Conclusions: After treatment, resolution of ROP was noted in approximately 90 % of the patients who had treatment-requiring ROP. 10 % of patients treated with IVB, IVR, Laser surgery and combined therapy however, did not respond and progressed to retinal detachment. This prospective study provides information about the development of ROP in preterm infants in the capital city of Mongolia. The distributions of BW and GA among infants developing ROP in Mongolia differ from those found in higher-income countries, and are comparable to other low and middle-income countries. We used a secure, web-based data collection and retrieval system that could be extended to multiple countries, which is now equipped with a telemedicine platform enabling remote grading of fundus images.

Introduction: Biliary Atresia is a fibroobliterativedisorder of the intra andextrahepatic bile ducts in infancy, which isgoing progressively cholestatic liver disease.The failed Kasaiportoenterostomy requiresliver transplantation. The goal of this studyis to show the outcome of Kasai operation,recent improvement and correlation the datato overseas.Methods and Materials: This study wasconducted in the department of generalsurgery of National Center for Maternal andChild Health of Mongolia between 2010 and2016 on a total of 66 infancies with biliaryatresia.Results: Patient diagnosed with biliaryatresia, which performed Kasai operationwithin first 2 months the outcome is verygood early and late post-operation period.There were 3 patients with 10 year survival, 4patients with 5-10 year and 28 patients with5 year survival after Kasai operation. The mostcomport age for liver transplantation is 1 yearlater after Kasai operation in Mongolia. Livertransplantation programme is necessary forMongolian pediatric surgery, and we thoughtour team was assembled.Conclusion: The children with biliary atresiaperform the Kasai operation within 2 monthsthe outcome is very good. Children with biliaryatresia often experience long wait times fortransplant unless exception points are grantedto reflect severity of disease.In Mongolia livertransplantation done in 2 child.

BackgroundIgA nephropathy and MPGN are common glomerulonephritis in the world that progresses slowly andrenal function can even remain unchanged for decades. Clinically, it presents by isolated hematuria,proteinuria. Histologically, IgA nephropathy presents with acute glomerular damage, mesangial cellproliferation, endocapillary leucocyte infiltration, and crescent formations, these lesions can undergoresolution with sclerotic healing. Since 2013, renal biopsy has been done at the First Central Hospitalof Mongolia a few times. However, the confirmative diagnosis of IgA nephropathy and MPGN remainunknown in Mongolia by renal biopsy. Therefore, we intended to test renal biopsy techniques andconfirm its diagnosis by renal biopsy at the Second Central Hospital of Mongolia.MethodsUltrasound guided renal biopsy had been done for four patients by nephrologist at the Departmentof Nephrology of the Second Central Hospital of Mongolia. All four specimens were evaluated assatisfactory which show more than 8 glomerulus under the light microscopy. Each renal cortical tissuewas divided into two tips: one piece for routine H&E stain and special stains, including Masson’strichrome, and PAS stain; another piece for immunofluorescence by frozen section, which werestained with IgG, IgM, IgA and complement component 3 (C3). Each case was screened by threepathologists.Results:The case which shows mesengial widening, mesengial hypercellularity under the light microscopyor mesangial granular deposition of IgA and C3 by immunofluorescence was diagnosed as IgAnephropathy. We obtained crescent formation with glomerular adhesion in most cases. In addition, weobserved secondary MPGN in one case, which is caused by hepatitis C virus infection.Conclusion: Probably, it is a new step for developing pathologic diagnosis for nephrology in Mongolia.We needs further study for improving renal biopsy technique and confirming the diagnosis of IgAnephropathy and MPGN using electron microscopy and pathological report by oxford classification forIgA nephropathy.